The first Covid-19 vaccine developed in the Southern hemisphere enters Phase 1 human trials in Adelaide

The first Australian-developed candidate to reach human trials, Vaxine began a Phase I trial in early July in Adelaide. The trial will test 40 healthy candidates and results are expected in six to eight weeks, according to the Australian Financial Review. “From there we will look to commence phase II and III trials straight away,” […]

Sypharma partners with Vaxine Pty Ltd. to manufacture COVID-19 vaccine product

“This is the 16th vaccine to enter trials globally but is the first COVID-19 vaccine developed in the Southern hemisphere to enter human trials, and the first COVID-19 vaccine designed with the help of AI,” said Professor Nikolai Petrovsky. Sypharma has a long-standing relationship with Vaxine with over a decade of manufacturing Advax delta inulin adjuvant, […]

Flinders University scientists led by Tasmanian Professor Nik Petrovsky on track to have a vaccine by the end of the year

The first COVID-19 vaccine to be developed in the southern hemisphere has progressed to human trials. But the company behind it is funded by the United States’ National Institute of Allergy and Infectious Diseases, so will it stay in Australia? Duration: 17min 40sec Broadcast: Fri 3 Jul 2020, 8:30am link to the podcast